Finally, CCK2R tumor imaging ([177Lu]Lu-PP-F11N SPECT/CT) was compared with somatostatin receptor subtype 2 (SSTR2) PET/CT imaging ([68Ga]Ga-DOTATOC or [68Ga]Ga-DOTATATE) in all patients. This evidence concerns the gene SSTR2 and neoplasm.